Mariken Stegmann

References  1.   Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global Cancer Statistics 2018:  GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.  CA Cancer J Clin. 2018;68:394–424.   2.   Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and  mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J  Cancer. 2018;103:356–87.   3.   Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez‐Jaramillo P, Gupta R, et al. Variations in  common diseases, hospital admissions, and deaths in middle‐aged adults in 21 countries from  five continents (PURE): a prospective cohort study. Lancet. 2019;6736(19):1–10.   4.   Pallis AG, Fortpied C, Wedding U, Nes MC Van, Penninckx B, Ring A, et al. EORTC elderly task  force position paper : Approach to the older cancer patient. Eur J Cancer. 2010;46(9):1502– 13.   5.   Wagland R, Richardson A, Armes J, Hankins M, Lennan E, Griffiths P. Treatment‐related  problems experienced by cancer patients undergoing chemotherapy: A scoping review. Eur J  Cancer Care (Engl). 2015;24(5):605–17.   6.   Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, Kiehl M, et al. New drugs, new  toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their  management. Crit Care. 2017;21(1):1–11.   7.   Engelhardt EG, Pieterse AH, van der Hout A, de Haes HJCJM, Kroep JR, Quarles van Ufford‐ Mannesse P, et al. Use of implicit persuasion in decision making about adjuvant cancer  treatment: A potential barrier to shared decision making. Eur J Cancer. 2016;66:55–66.   8.   Dronkers EAC, Mes SW, Wieringa MH, van der Schroeff MP, Baatenburg de Jong RJ.  Noncompliance to guidelines in head and neck cancer treatment; associated factors for both  patient and physician. BMC Cancer. 2015;15:515.   9.   O’Connor AM, Légaré F, Stacey D. Risk communication in practice: The contribution of  decision aids. Br Med J. 2003;327(7417):736–40.   10.   Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, et al. The prevalence and  outcomes of frailty in older cancer patients: A systematic review. Ann Oncol.  2015;26(6):1091–101.   11.   Summeren JJ Van, Haaijer‐Ruskamp FM, Schuling J. Eliciting Preferences of Multimorbid  Elderly Adults in Family Practice Using an Outcome Prioritization Tool. JAGS. 2016;   12.   Fried TR, Tinetti M, Agostini J, Iannone L, Towle V. Health outcome prioritization to elicit  preferences of older persons with multiple health conditions. Patient Educ Couns.  2011;83:278–82.   13.   Emanuel E, LL E. Four Models of the Physician‐Patient Relationship Four Models of the  Physician‐Patient Relationship. JAMA. 1992;267(16):2221–6.   14.   Chewning B, Bylund CL, Shah B, Arora NK, Gueguen J a., Makoul G. Patient preferences for  shared decisions: A systematic review. Patient Educ Couns. 2012;86(1):9–18.   15.   Rood JAJ, Nauta IH, Witte BI, Stam F, van Zuuren FJ, Manenschijn A, et al. Shared decision‐ making and providing information among newly diagnosed patients with hematological  malignancies and their informal caregivers: Not “one‐size‐fits‐all”. Psychooncology. 2017  Dec;26(12):2040–7.   16.   Brom L, Pasman HRW, Widdershoven GAM, Van Der Vorst MJDL, Reijneveld JC, Postma TJ, et  al. Patients’ preferences for participation in treatment decision‐making at the end of life:  Qualitative interviews with advanced cancer patients. PLoS One. 2014;   17.   Stiggelbout AM, Pieterse AH, De Haes JCJM. Shared decision making: Concepts, evidence, and  practice. Patient Educ Couns. 2015;98(10):1172–9.   18.   Vermunt NP, Harmsen M, Elwyn G, Westert GP, Burgers JS, Olde Rikkert MG, et al. A three‐ goal model for patients with multimorbidity: A qualitative approach. Heal Expect.  2017;(October):1–11.   14 Chapter 1